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Procedural sedation, also known as conscious sedation is used for minimally
invasive procedures performed outside the operating room where pain or surgical
stimulation is not great enough to require general anesthesia. These cases include
procedures such as catheter placement, endoscopy, certain plastic procedures, dental
procedures, dermatological procedures and certain pulmonary procedures.
These are procedures where sedation and a light analgesic effect are needed but
anesthetic depth requiring intubation and mechanical ventilation is avoided.
Unfortunately, these sedations are not typically attended to by a fully trained
anesthesiologist so the caregiver administering the drug does not have a very intuitive
feel for the anesthetic depth of their patient. Accordingly, it is quite common for the
caregiver to under dose leading to elevated heart rate and blood pressure or even regain
of consciousness (which I myself experienced once when undergoing a dental implant
procedure) or over dosing causing apnea. In the latter case the caregiver has to call an
anesthetist to bag ventilate or intubate and mechanically ventilate the patient until
spontaneous breathing is regained. Both situations are very undesirable.
To help prevent such dosing errors, Dwayne Westenskow has developed a
simulation system to predict the synergistic effect for Propofol (Prop), a sedative, and
Remifentanil (Remi), an opioid, when administered together. Remi and Prop are
commonly administered together in varied amounts to get a desired sedation and pain
relief in both general anesthesia as well as procedural sedation. This simulator uses
pharmacokinetic models to determine effect site concentration from the drug

administrations, and then uses pharmacodynamic models to map these concentrations to a
probabilistic drug effect surface. The effect of Prop and Remi together are so highly nonlinear and synergistic that it’s easy to understand why caregivers less experienced with
anesthetic drugs can easily over or under dose during procedural sedation. However,
with the simulator described above, a close estimate of drug effect site concentration and
remi/prop synergy can by calculated from the dosing regimen and displayed graphically.
This can provide the caregiver an idea of anesthetic depth, which is difficult to assess
from simple observation. Of greater value is the model’s ability to predict the future drug
effect on-line so the caregiver can see what the anesthetic level will be over the next few
minuets and take action before a critical event occurs.
As a validation of this model, we obtained a data set for eight subjects undergoing
procedural sedation wherein the investigator started the subject on a specified dosing
regimen of remi and prop and requested the subject to squeeze a ball about every 16
seconds. The time required for the subject to respond by squeezing the ball was
recorded. We used the dosing regimen to model the effect site concentration of remi and
prop at each data point and color-coded the data according to the response time. We
plotted the data on a two dimensional plot with remi and prop effect site concentrations
as the x and y-axis. The z-axis or third dimension of the plot is the population probability
of response or no response to the selected stimulus surface. We selected the algometry
surface. A population probability surface for algometry shows the probability of
responding to the stimulus at a given effect site concentration of remi and prop for any
member of the population. Thus, the x-axis and y-axis show remi and prop

concentrations and the z-axis is a scale from 0 to 1 or 0% to 100% indicating the
probability of not responding to algometry.
Figure 1 is an example graph for one of the eight data sets. The two horizontal
dark lines represent slices through the surface at 50% probability of non-response (EC50
isobol) and 95% probability of non-response (EC95 isobol). If a subject has an effect site
concentrations of remi and prop that correspond to any point along the EC50 isobol, we
expect the subject to have a 50% probability of responding to algometry.

To make the figure printable in black and white, we replaced the color-coding of each
data point with a simple solid black/open white scheme indicating response or nonresponse. Subjects that responded in less than 14 seconds by squeezing the ball were

marked as responders. In figure one we can fallow the course of anesthetic starting at
0,0. We can see that this subject received a bolus of Remi fallowed by an infusion of
Prop after the Remi nears its peak effect. Then the subject is maintained near the EC95
with infusions and small boluses. We can make two interesting observations from this
data set. First, a high probability of non-response is reached and maintained for more
than a minute before loss of response is observed. This can most likely be attributed to
surgical stimulus. A subject’s ability to respond to verbal or other types of stimulus is
highly dependent on the stimulus caused by the procedure at that moment. So a subject
experiencing algometry in isolation would very likely not respond near the EC95. But
with the added stimulus of the procedure, some stimulus threshold is more easily crossed
and the surface is less reliable. The second interesting observation is that the subject does
not start to respond again until the effect site concentration has almost reached zero
probability of non-response or zero on the z-axis. It would be a stretch to attribute such
lack of responsiveness entirely to lack of surgical stimulus, indicating that hystereses of
the drug effect causes a greatly shifted surface for return of response as compared to loss
of response. These two observations are seen in all eight data sets.
This is a three-dimensional surface but typically it is given in a two dimensional
graph with two curves corresponding to the EC50 and EC95. This does not illustrate the
complete shape of the surface but indicates roughly the probability of non-response.
Figures 2 through 9 show the eight data sets in a two dimensional form. Compare figure
one with figure nine to see the difference in visualization between the two methods.

Note the great variability in drug sensitivity among the eight subjects. Some
subjects are less sensitive, continuing to respond above the EC95 as in figure 3 or loosing
response below the EC50 as in figure 6.

Despite variability, the model does predict effect site concentrations between the
EC50 and EC95 when loss of response was observed for most of the eight subjects, thus
the data presented would be valuable to the care giver if viewed during the procedure in
real time as a means of estimation anesthetic depth.

To date, the simulator has the

ability to indicate drug effect site concentration and the subject’s probability to
responding to some stimulus. We have become interested in adding another level of
assessment by using end tidal CO2 and minute volume to predict and display an isobol
line on the surface indicating the effect site concentrations of remi and prop which would
result in the patient becoming apneic. In other words, the model currently shows if the
patient is sedated enough. We hope to add the other boundary showing if the patient is
too sedated for conscious sedation and likely to stop breathing.
Creating a surface describing ventilation or minute volume as a function of the
two drug concentrations is more complex and prone to error than the simple response to
stimuli surfaces because ventilatory drive is so heavily dependent on arterial CO2, drug
sensitivity and surgical stimulus. As anesthesia is induced, ventilatory drive decreases
leading to decreased minute ventilation. This causes an elevation in arterial CO2. The
increased CO2 increases ventilatory drive so the patient continues breathing. This cycle

holds unless the induction of anesthesia is to rapid, and the CO2 can’t elevate fast enough
or if anesthetic depth is sufficiently great such that elevated CO2 no longer affects
ventilatory drive. This interplay is further complicated because elevated CO2 causes
elevated heart rate, carrying the drug to the effect site (the brain in our case) more quickly
causing accelerated drug effects. A population surface for ventilation would have to be
determined for each level of arterial CO2.
We are currently considering a more patient specific approach by measuring end
tidal CO2 and minute volume both before drug is administered and during the procedure
then fitting the rough ventilation surface reported in literature to the patients actual values
to give a more accurate estimate of when apnea may occur. This would be accomplished
by applying a simple function reported in literature, which relates minute volume as a
function of CO2 for subjects without sedatives. This model would be shifted such that its
predicted resting minute volume and CO2 match that of the subject. The surface would
be fit to pass through this point at the zero remi and prop conc. point on the 3-D surface.
The second point that the surface would be forced to pass through would be the patients
actual minute volume at the modeled concentration of remi and prop. Thus the surface
would be shifted and tilted to fit the subject’s actual minute volume in real time giving a
more accurate prediction of the danger of apnea. If this method proves successful,
caregivers administering remi and prop in procedural sedation will be warned of a
possible critical event before it happens and better determine the dosing necessary to
maintain their patient at a safe level of sedation.

